Affiliation:
1. Center for Education and Health, Federal University of Campina Grande, 58175-000, Cuité-PB, Brazil
2. Department of Chemistry,
Federal Rural University of Pernambuco, 52171-900, Recife-PE, Brazil
3. Center for Education and Health, Federal University of Campina Grande, 58175-000, Cuité-PB, Brazil | Department of Chemistry,
Federal Rural University of Pernambuco, 52171-900, Recife-PE, Brazil
Abstract
Abstract:
The use of 1H-1,2,3-triazoles has become an important scaffold for applications in
different technological sectors. Therefore, we sought to carry out technological monitoring to
understand the international scenario involving 1H-1,2,3-triazoles from the patents filed, in
addition to evaluating the relationship between the growth in the number of patents and the
improvement of strategies for obtaining these compounds via a metal-catalyzed azide-alkyne
cycloaddition reaction. Technological monitoring was performed with the support of the PatentInspiration
® platform, using the keywords "1,2,3-triazol", "1,2,3-triazole", and "1,2,3-
triazolyl". A total of 960 registered patents were found, most for the years 2014 and 2019. The
main filers were prestigious multinational companies, such as Syngenta, Merck, Sandoz,
Pfizer, and Bayer. The United States, China, Japan, and Germany lead patent registrations,
mainly addressing innovations in chemistry and metallurgy, human needs, and new technologies. These results help
to understand the state of innovation for this topic, pointing out the characteristics of the main discoveries concerning
1H-1,2,3-triazole derivatives.
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico – CNPq
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – CAPES
Publisher
Bentham Science Publishers Ltd.